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ABSTRACT 
 
The study would like to assess the impact of procurement processes on availability of 
medicines and medical supplies in Malawi, a case of Central Medical Stores Trust 
(CMST). The participants selected for this study were 30 from health centres and 
hospitals in Malawi and 29 responded to the interview questions. The   study used   a 
simple random and purposive sampling technique to come up with participants to the 
study.  
 
The data collected was analysed using thematic approach to look at trends. The results 
of the study reveal that the stock level of supply of medicines and medical supplies is 
not good. The majority of the participants interviewed said that stock level of supply was 
very low followed by those who said it was moderate. Most of the participants 
interviewed in this study said that CMST management lacked strategic planning and 
also poor quantification while some cited political interference and that the medicines 
and medical supplies had a short expiry date.  The participants were further concerned 
that sometimes CMST recalls products but does not replace and this leads to many 
patients being returned and to buy medicines and other medical supplies to private 
pharmacies while some have said that the requested items are not supplied in full.  
 
Again, most of the participants interviewed revealed that lack of medicines and medical 
supplies meant failing to give medicines to all the patients throughout the year and 
when products that did not match are returned CMST does not replace and this leads to 
stock outs. The participants in the study strongly said that there had no alternative of 
getting medicines and medical supplies while others said would place emergency 
orders. Moreover, most participants also revealed that good procurement will ensure 
constant availability of medicines all the time. Some have said that when products are 
not overstocked expiry is avoided and hence losses are reduced. Again when asked 
about the advantages of good procurement and inventory management of drugs, other 
participants revealed that potency of medicine can be maintained through good 
inventory management.  
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CHAPTER ONE: INTRODUCTION 
 
1.1. Introduction 
Procurement is an important part of efficient drug management and supply and is an 
important procedure for all levels of health care institutions. Ombaka (2009) argues that 
an effective procurement process ensures the availability of the right drugs in the right 
quantities, available at the right time, for the right patient and at reasonable prices, and 
at recognizable standards of quality.  
 
1.2. Background to the Problem 
 
The Government of Malawi (GoM) formed Central Medical Stores (CMS), an arm of the 
government with a responsibility for three core activities; procurement, storage and 
distribution of medicines and medical supplies, to all government and Christian Health 
Association of Malawi (CHAM) hospitals and other health centres. CMS was under 
Ministry of Health (MoH). CMS‟s mission was to be the public choice supplier of 
uninterrupted good quality, safe, proven efficacious and affordable medicines and 
medical supplies. However, contrary to the mission statement there are reports of poor 
performance by the organization. There are reports of underperforming with reports on 
stock outs, under stocks and over stocks of essential medicines and medical supplies. 
There are also reports of pilferage of commodities, destruction of medicines and 
medical supplies worth millions dollars due to expiry and obsolescence. Chirwa (2012), 
indicated in his dissertation, the availability of medicine was at 33% in 2008 and 35% in 
2009 representing a 2% improvement. Chirwa (2009) also noted that despite the stock 
outs, many products were expiring on the shelf, as a sign of poor inventory 
management. 
As a solution to this, GoM decided to turn CMS into a Public Trust with the aim of giving 
it autonomy in carrying out its activities. CMS was then given a Trust Status through the 
Trust Deed in November 2011 and it became Central Medical Stores Trust (CMST). The 
purpose was to give the organization Financial and Management independence with the 
aim of improving its performance. CMST started operating independently in June 2012 
when the Executive Management was elected. 
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1.3. Statement of the Problem 
CMST was turned into a Public Trust with the same view, aimed at giving it independent 
decision making and therefore improve performance. According to National Health 
Management Information System routine data as reported by Lapukeni (2012) in his 
dissertation has shown that CMS faced erratic supply of essential health products in all 
health facilities. Internal Central Medical Stores stock reports have also confirmed the 
regular stock-outs for vital essential medicines. He further argued that the facilities had 
developed lack of confidence in Central Medical Stores leading to procurement of health 
products from the private suppliers usually at a prohibitive higher cost and thus 
confirming the erratic and unreliable nature of the supply chain system. Lapukeni‟s 
(2012) research findings at CMS have revealed the need to adopt third party logistics to 
improve efficiency whilst proposing internal systems strengthening as an exit strategy. 
The researcher found it necessary to assess the availability of medicines and medical 
supplies after CMST was made independent taking into account Lapukeni‟s (2012) 
recommendations of 3PL.In view of the procurement processes suggested and meant 
to improve performance there is little that has been done to fully have the medicines 
and medical supplies available in health facilities despite making the CMST a public 
trust as a way of improving performance. Kasakura (2014) also argues in his article 
titled: ”Drug Stock Outs likely to stay”. The article doubted whether setting of CMST by 
government a few years ago would entirely change things for the better in public 
hospitals. Therefore, the study would like to assess the impact of procurement 
performance processes on availability of medicines and medical supplies in government 
and CHAM hospitals. 
1.4. Aim of the Study 
The aim of the research is to critically assess the impact of procurement performance 
processes on availability of medicines and medical supplies. 
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1.5. Research Objectives 
The following are the objectives: 
 To review relevant literature on the supply of medicines and medical supplies at 
CMST. 
 To compare the current performance on supply of medicines and medical 
supplies at CMST with that previously found by Lapukeni (2012) research. 
 To investigate reasons for change between the two studies. 
 To make recommendations for improvement. 
1.6. Research Questions 
The following are research questions: 
 What is the supply of medicines and medical supplies at CMST? 
 How effective is the supply of medicines and medical supplies at CMST? 
 Are there changes which have been observed at CMST? If yes, give an 
explanation for these changes. 
 
1.7. Significance of the Study 
The study will help management to consider streamlined processes and independent 
decision making by the organization to reduce procurement cycle time and therefore 
reduce lead time. Unique resources like; adequate finances, skilled human resources 
and ideal warehousing facilities are underpinning elements for any organization to run 
effectively. The findings from this study will help formulate strategic plans that will help 
to minimize these problems so as to ensure constant and uninterrupted supply of 
medicines in the hospitals. Again, CMST will benefit in this study as the considered 
recommendations will help speed up the procurement of medicines and subsequently 
their availability in the hospitals. 
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1.8. Format of the Study 
Chapter one covers topics such as background   of   the study, the problem statement, 
research objectives and research questions. In addition the significance of this research 
study has been covered.  
Chapter two provides relevant literature to the topic under study. 
Chapter three covers the research methodology used the population, sample, research 
design, and instrument for data collection as well as how data will be collected. 
Chapter four outlines the results, discussion and interpretation of findings of the study. 
Chapter five gives conclusions and gives recommendations. 
1.9. Conclusion 
The supply of medicines needs to be managed efficiently in order to prevent all types of 
wastage including overstocking, pilferage and expiry. This wastage reduces the quantity 
of medicines available to patients and therefore the quality of health care they receive. 
Both under stocking or overstocking and expiry of medicines highlight problems within 
the supply chain activities which include selection, quantification, procurement, storage, 
distribution and use. The foregoing chapter has covered the introduction, discussed the 
background information to the problem statement, research objectives, research 
questions as well as the significance of the study to CMST.  
Chapter Two which follows covers relevant literature review on the topic understudy. 
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CHAPTER TWO: LITERATURE REVIEW 
 
2.1. Introduction 
Churchill and Iacobucci (2002) state that literature search or review naturally depends 
on the problem being addressed. The researcher would like to assess the availability of 
medicines and medical supplies at CMST, and the researcher would therefore review 
the literature on previous researches carried out on the performance of the old CMS 
and compare with the present situation. 
2.2. Definition of Terms 
a. Procurement 
Procurement refers to the process by which a health system acquires the selected 
medicines (.Gordon 2010) 
b. Purchasing-The activity of acquiring goods or services to accomplish the goals of 
an organization. (Ombaka 2009) 
c. Logistics Management - Logistics management is a supply chain function that 
plans, implements, and controls the efficient, flow and storage of goods, services to 
meet customers' requirements.  Logistics management is an integrating task that 
coordinates all logistics activities, as well as integrating these activities with 
marketing, operation management, finance, and information technology Council of 
Supply Chain Management Professionals (CSCMP 2011, cited in Odoom 2012). 
d. Supply Chain Management-Supply chain management focuses on the 
management of supply chain activities to help to take advantage of customer value 
and attain a sustainable competitive advantage.  It represents effort by supply chain 
firms to develop and run supply chains in the most effective and efficient ways 
possible.  Supply chain activities focus on product development, sourcing, 
production, and logistics, as well as the information systems needed to coordinate 
these activities. (Handfield 2011,cited Odoom,2012) 
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e. Third Party Logistics (3PL), The3PL (third-party logistics) is a provider of 
outsourced logistics services. Logistic services encompass anything that involves 
management of the way resources are moved to the areas where they are required. 
f. Availability 
Availability is the capacity to have inventory when desired by a customer. As simple 
as this may seem it is not at all uncommon for an organisation to expend 
considerable time, money and effort to generate customer demand and then fail to 
have products available to meet customer requirements. It should be clear that 
achieving high levels of inventory availability requires a great deal of planning 
(Ombaka 2009) 
g. Storage 
Proper storage on inventory is vital .Improper storage can cause a product to ruin, 
resulting in a loss of inventory and money. 
h. Operational performance 
Operational performance deals with the time required to deliver a customers‟ order. 
Whether the performance cycle in question is market distribution, manufacturing 
support, or procurement, operational performance is specified in terms of speed of 
performance, consistency, flexibility and malfunction recovery (Odoom 2012). 
According to Lapukeni(2012) there are many steps in the procurement process and no 
matter what model is used to manage the procurement and distribution system, efficient 
procedures should be   in   place: to select the most   cost-effective essential drugs to 
treat commonly encountered diseases; to quantify the needs; to pre-select potential 
suppliers; to manage   procurement   and   delivery; to ensure   good   product quality; 
and to monitor the performance of suppliers and the procurement system.  Failure in 
any of these areas leads to lack of access to appropriate drugs and to waste. 
Procurement is not simply the act   of buying    but   encompasses a complex range of 
operational, business, information technology, safety and risk management, and legal 
systems, all designed to address an institution‟s needs (Ombaka 2009).   Specifically, 
management   of  medicines procurement determine, accredit, and monitor appropriate 
supply  sources;  evaluate  suppliers‟  performance;  choose  a  buying  strategy   or   
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approach; monitor   drug   delivery;   assess   clinical   and   use outcomes;  and     
evaluate new products and    the    drug    market. Successful  hospital    procurement  
is  also   a   collaborative     process, involving  people     with skills   in  purchasing, 
finance, management, clinical   and   nursing   specialties,   pharmacy,   quality   control,   
and   even the end user: the patient(Ombaka,2009). 
While different national procurement models exist across developing countries, 
procurement of essential medicines to serve many of these populations remains largely 
centralized in the Ministry of Health and/or a Central Medical Store (CMS) and relies 
heavily on public monies, international funding mechanisms, and donor funding World 
Health Organization (WHO 2011). These public entities often lack the technical capacity 
to efficiently and strategically carry out the procurement process. Inadequate planning 
and forecasting, use of archaic procurement methods, and tendering yearly or multiple 
times a year contribute to high commodity costs, long lead times, stock imbalances, 
and, overall, commodity insecurity(WHO 2011). Indeed, across all WHO regions, the 
mean availability of selected medicines is consistently lower in the public sector than in 
the private sector (Cameron A, Ewen M, Ross-Degnan D, Ball D, Laing R 2009,p.373). 
2.3. Central Medical Stores Performance Before Becoming A Trust 
According to Mmana (2011), procurement audit reports for 2010 at the Malawi Ministry 
of Health headquarters which controlled the single government instituted supplier 
namely Central Medical Stores (CMS), uncovered irregularities in the procurement of 
medicines that consequently resulted in Health Sector-Wide Approach (HSWAp) pool 
partners withholding funds meant for the procurement of medicines until the situation 
was rectified. This and other challenges external to hospital procurement functions „can 
directly affect the downstream customer (the patient) in public hospitals (Miocevic2011 
cited by Kanyoma & Khomba 2013).This meant that CMS could not have sufficient 
inventory of medicines and could therefore hardly meet the drug requirements of public 
hospitals. This also meant that CMS was going to fail to procure and supply medicines 
and other medical supplies because of inadequate funding which subsequently would 
affect the patients in the hospital in dire need of the items. Hence, there was an urgency 
need for CMST with government to improve the situation at hand. 
8 
 
As earlier explained in the background to the study, the entire supply chain process 
should ensure uninterrupted supply of health products in all the health facilities. 
Currently, according to Lapukeni (2012) the supply chain shows serious flaw, leading to 
intermittent supply to delivery sites and this is further highlighted below. The evidence of 
this continuous shortage of health products is abundant as evidenced by the inability of 
the supply chain system to use the entire amount of the national budget for medicines 
and medical supplies. At CMST there was acute shortage of the supply of health 
products and this supply chain flaws affected the entire health sector leading to would 
be patients seeking medicine in private pharmacies. 
Graph 1: Showing Resources Allocation for Central Medical Stores 2004-10 budget in 
Malawi Kwacha (MK) 
 
Source: Health Sector Wide Approach Financing (2010) 
2.3.1. Persistent Stock- outs 
Though Graph 1 shows increased resource allocation by Health Sector Wide Approach 
Pool partners including Government, Central Medical Stores failed to translate this and 
utilize the resources leading to continuous stock outs (Lapukeni 2012). National Health 
Management Information System routine data showed erratic supply of essential health 
products in all health facilities. Internal Central Medical Stores stock reports confirm the 
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regular stock-outs, also for vital essential medicines. According to Lapukeni (2012)the 
facilities had developed lack of confidence in Central Medical Stores leading to 
procurement of health products from the private suppliers usually at a prohibitive higher 
cost and thus confirming the erratic and unreliable nature of the supply chain system. 
The lack of having good supply chain process has failed CMST and left most hospitals 
and other health centres with a shortage of health products. 
Central Medical Stores (CMS) as known in low-income countries are usually the 
backbone of public health procurement and distribution models (Yadav, Tata, 
&Babaley2011). These CMSs have traditionally been completely government-owned 
enterprises; but, more recently, they have been given management autonomy, with 
government oversight (Drug Supply Choices: What Works Best? 1998 cited in Watson 
& McCord 2013). The roles of the CMS have generally included the national 
procurement of healthcare commodities, storage and handling of inventory 
commodities, and distribution to various sections of the national public health system; 
and, in some cases, the private-sector health system. Although, conceptually, these 
models have all the necessary components for a supportive supply chain for healthcare 
delivery; in practice, CMSs are often characterized by inadequate performance in areas, 
such as procurement, financial and logistical management, security, and storage 
(Govindaraj &Herbst 2010, cited in Watson &McCord 2013). 
In Benin, the Central Medical Store (CAME) lacked the storage capacity to handle the 
volume of products purchased by various healthcare service collaborators; as a result, 
poor stock management practices occurred (Ndoye et al. 2009 cited in Watson & 
McCord 2013). In 2001, poor functioning by the CMS in Ghana was cited as the cause 
of shortages of essential drugs and supplies; improvements in availability during the 
next two years was more attributable to access to the open market than to 
improvements at the CMS (EGEVAL 2005, cited by Watson and McCord 2013). In 
some cases, prices at the CMS were higher than the open market. In Malawi, one 
deterrent to successfully providing an essential health package is the inability of the 
CMS to quantify need and hold adequate buffer stock (Mueller et al. 2011). In addition, 
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in Malawi, high profile cases of theft and corruption at the CMS have resulted in donors 
withholding funds meant for the health sector (Ngozo 2011). 
Many examples of CMS strengthening efforts do exist. In Tanzania, the performance of 
the CMS improved after a systematic approach to management, supply monitoring, and 
documentation (Wiedenmayer 2000). Using multidisciplinary training and procurement 
policy changes, the Association of Central Medical Stores for Essential Drugs (French 
acronym, ACAME) improved the performance of national CMSs in many Francophone 
African countries (Millot2006, cited in Watson & McCord 2013). Mwangonde (2013), in 
his dissertation stated that donor partners then stopped giving Malawi CMS financial 
support and promised to resume aid only if CMS was turned into a Public Trust. 
Ombaka (2009) argues that when procurement is conducted without a systematic 
process, it often leads to unacceptable outcomes. According to him, the operational 
principles of a good procurement process are the backbone of any medicines 
procurement. These principles ensure the selection of the most cost effective essential 
drugs to commonly encountered diseases and that the quantification, supplier selection, 
delivery schedule, product availability, quality, and supplier performance are correct and 
properly monitored (Ombaka 2009). 
Therefore, an effective procurement process at any level must ensure that four strategic 
objectives are achieved (Ombaka 2009); 
 The procurement of the most cost effective drugs in the right quantities; 
 The selection of reliable suppliers of high quality products; 
 Procurement and distribution systems that ensure timely and undisturbed 
deliveries and processes that ensure the lowest possible total cost (WHO 2008, 
cited by Ombaka,2009). 
Kachieng'a &Ogara(2004) cited Zamboko, Tripathi & Kamuzora (2012) reviewed the 
processes of equipment planning, procurement and management in public hospitals in 
Kenya and South Africa. They observed that procurement and management of health 
equipment required change in the approach, as it affects the quality of the healthcare 
services.   Studies on medical equipment procurement in African region indicate the 
11 
 
technical expertise of the tender-board members remain a matter of concern and thus, 
affecting both the cost and quality of medical-equipment procurement management 
process (Ncayiyana 1997; Kachieng'a 1998 cited in Zamboko,Tripathi&Kamuzora2012). 
A different factor for the shortage of medicines and medical supplies could be 
unavailability of skilled and enough staff at the CMS. In a study undertaken in 2008 by 
USAID it was found that CMS had no skilled and enough staff which affected its supply 
chain management (Mabveka 2013). This meant that it had no adequate capacity to 
undertake procurement activities which includes procurement planning and 
management of the procurement process. Therefore, as put by (Mabveka 2013) there 
were high chances that the procurement that was undertaken in 2009 was poorly 
planned which resulted into the shortage which was there by then. For instance, instead 
of planning for a framework agreement with the successful bidders, the CMS may have 
entered into a one-off contract. This meant that the CMS had to restart the procurement 
cycle within a short period of time after just concluding another one( Mabveka,2013). In 
addition, due to understaffing or being staffed with unskilled staff, the bid preparation 
could have been affected. In this case the first instance could be that the bidding 
documents took a long time to be finalised or the bidding document had many mistakes 
which led to many bidders seeking clarifications which resulted into addendums. The 
addendums that largely affect the preparation of bids by suppliers resulted into 
extended bidding period. Therefore, availability of appropriate human resource does 
negatively affect a procurement process. 
Mabveka (2013) had also pointed out that mismanagement of funds could be another 
form in the way on how the contract payments were done. It could be possible that 
payments for the yet-to be and delivered medicines and medical supplies were not 
made per the contract agreements, hence affecting the procurement of drugs. For 
instance some contracts could require upfront payments but they were not made. This 
could have been the case either because the funds were not transferred from Treasury 
or were used for other things. According to Mabveka (2013) the former case could 
happen where the political masters may have directed that the funds be made available 
for other expenditures rather than the one they were planned for at that time. In case 
12 
 
where the suppliers were not paid their up-front payments, the suppliers could not 
deliver/supply. In a different case where supplied medicines and medical supplies were 
not paid for, the suppliers could not be interested in submitting a bid when an invitation 
to be was made again (Mabveka,2013). As a result, it could have taken a long period to 
identify new reliable suppliers. This could force the CMS use the Request for quotation 
(RFQ) method of procurement which mostly target the third party suppliers, the so 
called middlemen in medicines and medical supplies business. 
In reference to the foregoing, the CMS had to ensure that it enters into contracts with 
suppliers in a form of contract that will be in tandem with the time it took to identify them. 
In addition, considering that it deals with goods which are critical in nature for saving the 
human life the best type of contract that CMS could have been entering into with 
successful bidders is framework agreements. This could mean the suppliers supply the 
medicines and medical supplies more than once. In this way, the CMS would ensure 
that there was a continuous supply of medicines and medical supplies (Lapukeni 2012). 
 
There are many forms corruption takes in procurement which include patronage system. 
Patronage takes place when local public office holders among other things grant 
favours, jobs and contracts in return for political support. All these are done in disregard 
of formal rules at the expense of personal channels (Andvig et al., 2001 cited in 
Mabveka, (2013). They further argue that procurement fraud does happen when both 
the public officers and politician choose to close their eyes on economic crimes, and it is 
serious fraud when they have an active role in it. Søreide (2002) (cited by Heggstad, 
K et al. (2010) and cited by Mabveka (2013) states:“Corruption in public procurement 
makes the officials or the politicians in charge purchase goods or services from the best 
briber, instead of choosing the best price-quality combination”. The foregoing clearly 
shows that politicians do contribute to the occurrence of procurement corruption. This 
simply means that politicians do conflict and struggle with the legitimate primary players 
in the public procurement who happens to be public officer/officials, later alone other 
secondary players in the public procurement process.   
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The World Health Organization (WHO) defines access to medicine as a priority for 
citizens. It needs to be available at all times in adequate amounts, in appropriate 
dosage and quality and at an affordable price for individuals and communities (Marks, 
2009 and Yadav et al., 2011 cited by Schopperle, 2013).The procurement and supply 
management function plays an important role in healthcare delivery. Failure by the 
function to safeguard the availability of supplies can sabotage the very interests of the 
organization which the function is supposed to support (Kumar, Ozdamar & Zhang 
2008).Therefore, to ensure that people have access to essential medicines and to 
preserve the quality of the medicine, a functioning medicine supply chain is necessary, 
which includes procurement, appropriate warehousing and efficient transportation 
(Yadav et al., 2011).   
2.4. Procurement Process 
According to MSH (Management Sciences for Health, 2012 cited by Whitney 2014), “An 
effective procurement process seeks to ensure the availability of the right medicines in 
the right quantities, at reasonable prices, and at recognized standards of quality.” As 
such, procurement includes forecasting required drug quantities, setting production 
quality standards, choosing suppliers, comparing price quotations, and paying for the 
drugs.   
Procurement practices are used in the logistics and supply chain industry to support 
operational needs of the company by focusing on how purchasing is done, how the 
product is received from suppliers, building relationships with vendors and managing 
the procurement process by identifying opportunities and managing internal operations 
(Fantazy, Kumar, &Kumar, 2010, in Odoom,2012). In today‟s procurement environment, 
importance has been placed on reducing costs during purchasing which leads to the 
best costs and value to its customers 
 
Procurement is the business management function that ensures identification, sourcing, 
access and management of the external resources that an organisation needs or may 
need to fulfil its strategic objectives(CIPS,2005) Comparing with purchasing from supply 
chain management perspective, procurement emphasizes on relationships between 
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buyers and sellers and is in a higher, strategic level activity (Bowersox et al., 2002 , 
p.73). Bowersox et al. (2002, p. 74), discussed procurement perspectives mainly as: 
a. Continuous supply 
Production should be ensured with continuous material supply. Production stoppage 
increased operation costs and results in an inability to provide finished goods or service 
to customers. 
 
b. Minimize inventory investment 
Modern procurement is to maintain supply continuity with the minimum inventory 
investment possible. This requires balancing the costs for carrying excessive material 
against the possibility of a production stoppage. The goal could be to make materials to 
arrive before the scheduled production. 
 
c. Quality improvement 
Procurement can play a critical role in the quality of a firm‟s products or services. When 
used materials and parts are of poor quality, the finished goods quality will not satisfy 
customer requirements. Quality improvement through procurement also impacts on 
costs in the firm by scrap and rework in the production. 
 
d. Supplier development 
Successful procurement depends on locating or developing suppliers, analysing their 
capabilities, and selecting and working with those suppliers to achieve continuous 
improvement. 
According to Kanyoma & Khomba (2013) an effective supply chain is characterized by 
the timely, reliable movement of health commodities and data up and down the supply 
chain: from the service delivery point (such as health posts, clinics, and hospitals where 
health commodities are dispensed) to the district, regional, and national levels and 
back. Indeed, data from the service delivery points are the most relevant for supply 
chain managers to make informed decisions of how much, and what type of health 
commodities should be delivered (Kanyoma & Khomba, 2013). 
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According to Lapukeni (2012) in his dissertation pointed out that the sustained 
availability of medicines and medical supplies is crucial if quality health care service is 
to be achieved. He further pointed out that ensuring a sustained availability of these 
health products in the health service delivery points in the country requires proper 
quantification, forecasting, procurement process, appropriate warehousing and 
effective distribution strategies. In this regard the (CMS)under the policy direction of 
the central Ministry of Health was responsible for uninterrupted supply of these 
products. Therefore, the CMS had a role to play in making sure that there was effective 
supply chain management for pharmaceutical and related health products.  
For example, in Uganda, as put by Zamboko, Tripathi & Kamuzora (2012) The National 
Medical Stores (NMS) on many occasions failed to provide quality services in 
procurement, storage and distribution of medical supplies due to;  
 Lack     of  planning     both   at  the  policy   level  and   within    the  National 
Medical Stores,  
 Inadequate   supervision   and   control   mechanisms   leading to  commodity 
losses,  
  De-motivated, poorly trained and undisciplined work force,  
 Unstable funding and  
 Bureaucracy        .  
This    has   led   to inefficiencies   in   the National    Drug    supply    system, resulting   
into   inadequate   supply   of   appropriate   medicine   supplies   at health     facilities 
throughout the   country.  (Logistics    support - a publication of the Regional Centre for 
Quality of Health Care, 2000 cited by Zamboko, Tripath and Kamuzorai, 2012). 
The procurement capacity at CMS Malawi is quite limited and affects to a greater extent 
the efficiency of the supply chain Lapukeni (2012). The proposed strategic procurement 
interventions such as 3PL herein was aimed at ensuring that there is sustained and 
efficient integrated supply chain within CMS. Martin (1998) cited by Lapukeni (2012) 
observed that to achieve this, organisation wide supply chain integration, clearly 
requires a quite different orientation than that typically encountered in the conventional 
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organisation. The proposed strategy was establishing of supplier buyer relationship as 
well as strengthening internal systems such as warehousing and distribution. Therefore, 
if CMS was able to bring forward these strategic procurement interventions, the supply 
and distribution of medicines to health facilities was likely to improve. This will further 
lead to improvement in terms of availability as well as affordability of medicines and 
medical supplies. Proper organization, availability and affordability are crucial in making 
sure that pharmaceuticals are available in abundance in the health facilities. 
2.5. Supply Chain Management (SCM) Systems 
Supply chain management is part of a well-functioning health system. In strong health 
systems, supply chains respond to the requirements and goals dictated by the broad 
public health institution, operational environment, and society in which these supply 
chains operate. The healthcare supply chains are said to be more complex and more 
immature compared to other industries (Beier, 1995). This can be explained by different 
reasons. First, supply chain management has an impact on human health requiring 
adequate and accurate medical supply conforming to the patients‟ needs (Beier,1995). 
If medical supplies are out-of stock, distributed to the wrong patient or are prepared 
inadequately, patients may experience adverse events, and in some cases death 
(Mustaffa & Potter, cited by Kanyoma & Khomba, (2013).Integrated supply chains have 
collateral benefits for a health system. A cohesive, well-performing public health supply 
chain helps build the foundation for a strong pharmaceutical management system, 
provides essential information for managing health programs and financing 
mechanisms, and helps to achieve the level of accountability exemplified in the 
commercial sector. 
It can be argued that a well-functioning medicines supply management system is vital in 
assuring an uninterrupted supply   of   essential   medicines   that   are efficacious   and   
of   good   quality, physically and financially   accessible   and   used   rationally.   
Carrying   out   an   in-depth assessment of   the   system    provides information     for 
targeted interventions in strengthening   the system. 
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Therefore, the concept of supply chain is defined by Meijboom, Schimidt-Bakx&Westert 
(2011) as a way to envision all steps needed from beginning to end in order to deliver 
products or services to the customer. Supply chain management (SCM) on the other 
hand, involves the management of flows between and among stages in a supply chain 
to maximize  total profitability (Sila et al, 2006; cited by Kanyoma & Khomba,2013) and 
customer satisfaction (Danese and Romano, 2011, cited in Kanyoma & Khomba,2013). 
The procurement function occupies centre stage in managing supply chains. Juha and 
Pentti (2008) cited by Kanyoma & Khomba (2013), the function determines availability, 
cost, and quality of materials as well as responsiveness and flexibility of organizations in 
meeting customer needs and expectations. In recent years, various articles have noted 
the strategic importance and competitive potential of procurement or the purchasing and 
supply management (PSM) function (Gonzalez-Benito, 2007; Ogden et al., 2007 cited 
by Kanyoma &Khomba, (2013). 
The significance of SCM is further emphasized by Mustaffa and Potter, cited in 
Kanyoma and Khomba (2013) when they noted that within the healthcare industry, 
procurement operations associated with pharmaceutical products can affect the 
standard of care for patients. They contend that effective management of the function 
can ensure that both service level and cost objectives are met. Similarly, Kumar et al., 
(2008) suggest that procurement practices affect inventory levels and ultimately the 
service provided to the consumer or patient in the case of hospital. There is high risk 
therefore, that erroneous decisions in SCM can culminate into stock-outs (White and 
Mohdzain 2009 cited in Kanyoma & Khomba 2013) and total failure of healthcare 
delivery systems (Mustaffa & Potter, 2009, Kanyoma & Khomba 2013). Consequently, 
Kumar et al., (2008) rule out the feasibility of inventory elimination because medical 
supplies must be available for immediate use by medical professionals. 
Inventory management does not mean keeping medical supplies without distributing 
them. The main motive of the inventory management is to see that the medical supplies 
are enough and if not there is need to be procure. Thus, proper procurement of the 
medical supplies and quick supply of them will help in the delivery of the health care 
services. 
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2.6. Supply Chain and Inventory Management 
Effective   inventory   management   in   a   supply   chain can play a vital role in cutting 
inventory holding costs across the different stages of the supply chain, this is  especially   
so   in   developing   countries   like   Tanzania where    budget    for  medicines    are  
often  tight.  In a health   facility   overstocking   of   certain   items   may   tie up   a 
substantial   portion   of the   medicine    budget, leaving insufficient funds for other 
important perhaps lifesaving medicines (Wilson 2009). For this reason   it is very   
important to control the building up of inventory. In addition to cost holding, excess 
inventory can lead to obsolescence and reduce an enterprise‟s flexibility (Wilson 2009). 
In case of a health facility excess inventory may lead to   expiry of some medicines. 
According to Lapukeni (2012) effective inventory management in a supply chain can 
play a vital role in cutting inventory holding costs across the different stages of the 
supply chain. He further says that holding, excess inventory can lead to obsolescence 
and reduce an enterprise‟s flexibility. In case of a health facility excess inventory may 
lead to expiry of some medicines. Inventory management is the art and science of 
maintaining stock levels of a given group of items incurring the least cost consistent with 
other relevant targets and objectives set by management (Mpwanya 2005). It is 
important that managers in organizations who deal with inventory, to have in mind, the 
objective of satisfying customer needs and keeping inventory costs at a minimum level.  
Lufesi et al (2007) cited in Lapukeni (2012) assert that inventory costs include holding 
costs, ordering costs and shortage costs. 
The main aim of inventory management is to hold inventories at the lowest possible 
cost, given the objectives to ensure that there is uninterrupted supply for on-going 
operations. Therefore, when making decisions on inventory, management has to find a 
compromise between the different cost components, such as the costs of supplying 
inventory, inventory holding costs and results from insufficient inventories (Hugo, 
Badenhorst-Weiss & Van Rodyen, 2002:169) 
In order to manage the various types of inventory , attributes of items first must be 
analysed  in terms of cost, lead time, past usage, and the nature of demand ( Benton, 
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2007,cited Wild,2002).In many purchasing situations, there are a number of different 
considerations conflicting with one another that influence the final purchasing decision. 
Improvement of drug inventory management can significantly decrease the expenditure 
in great amount. 
Inventory control is the activity which organizes the availability of items to the customer. 
It co-ordinates the purchasing, manufacturing and distribution functions to meet the 
marketing needs. This role includes the supply of current sales items, new products, 
consumables, spare parts, obsolescent items and all other supplies (Wild, 2002, 
p.1)According to Wild (2002, p.7) the purpose of the inventory control function in 
supporting the business activities is to optimize elements such as customer service, 
inventory costs and operating costs. 
The most profitable policy is not to optimize one of these elements at the expense of 
others. According to Wild (2002, p.7) the inventory controller has to make value 
judgement. If profit is lacking, the company goes out of business in the short term. If 
customer service is poor, then customers disappear and the company goes out of 
business in the longer term. Balancing the financial and marketing aspect is the answer 
hence the stock controller should have a fine judgement to make. 
 
CSCMP (2011) cited by Odoom (2012) implies that supply chain management is 
successful when the goal of getting the right product to the right customer at the lowest 
costs is achieved.  This is a situation that will give the highest level of service to the 
customer and higher competitive advantage to the company.  Therefore, supply chain 
management touches on the mixture of different supply chain activities to help maximize 
a company‟s profit and total value. 
2.7. Procurement and Delivery of Healthcare 
Since services cannot be produced for storage like physical products, Meijboom, 
Schmidt-Bakx & Westert, (2011) cited in Kanyoma and Khomba (2013) note that 
providers adopt customer waiting as a remedy.  However, as a result of the differences 
between healthcare and other services, long waiting times are not affordable in 
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healthcare systems because patient condition may worsen substantially during the 
waiting (Mustaffa & Potter, 2009cited by Kanyoma &Khomba,2013). This therefore calls 
to duty all functions including procurement which must ensure that medical supplies are 
always available. Meijboom, et al. (2011) cited by Kanyoma & Khomba (2013) have 
underscored the role of the procurement function in healthcare systems. They contend 
that „simultaneity of production and consumption of services results in highly 
unpredictable and unique demand which is difficult to match with service capacity; 
hence the need for sufficient inventory. As Aronsson et al. (2011 cited by Kanyoma 
&Khomba) suggest, it really does not matter which dimension of performance 
measurements takes prominence (cost or customer satisfaction / healthcare quality), 
because both dimensions can be achieved through the PSM function. Such is the 
significance of the procurement function. Schopperle (2013) also adds that typical 
challenges within the national health systems which impact the supply chains include 
inadequate forecasting, insufficient funds, delays in funding disbursements and long 
lead times. 
The CMST would only be efficient if it is able to get funding in good time so that it 
procures medicines in good time and distribute them promptly to hospitals and other 
centres for effective medical intervention. However, the funding challenges continue to 
have an impact on the supply of drugs by CMST since it operates on thin budgets. 
2.8. Factors Affecting Procurement Processes 
a. Overstocking 
Consequently, the long-term effects of overstocking may become as expensive as the 
effects of under stocking where both scenarios lead to service unavailability and death 
of patients (Mustaffa& Potter 2009, cited by Kanyoma & Khomba 2013). The implication 
of rising expenses in the long run will either be reflected in fewer beneficiaries 
accessing free healthcare services at public hospitals, or more tax payer funds being 
spent on healthcare delivery (Chandra et al., 2009 cited by Kanyoma & Khomba 
2013).It is adequately important for CMST to procure medicines and medical supplies 
which will be enough to avoid the expiry of some of the drugs in the health care delivery. 
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b. Forces External to Procurement 
Further challenges come as a result of forces external to procurement. On this, Vries 
(2010) argues that inventory management decisions for hospitals are often made by 
many stakeholders who have conflicting interests. He notes that such decisions often 
seem to be more politically and experience-based rather than data-driven and 
potentially affect availability. Regardless of the interests of policy makers, Pan & 
Pokharel (2007) cited by Kanyoma & Khomba (2013) advise that it is prudent that some 
minimum stock of medical supplies be kept. Similarly, Vries (2010) encourages 
managers to clearly understand how inventory systems are affected by specific hospital 
characteristics, in order to improve healthcare inventory management. It is equally true 
that some policy makers and other political motivated individuals will politicize 
procurement of drugs for their own agendas which might put CMST in a quandary. It is 
important therefore for CMST to consider keeping medicines and medical supplies 
which will help in case of inadequate funding. 
c. Logistics in the Supply of Medicines and Medical supplies 
Tetteh & Pharm (2009) cited in Kanyoma & Khomba (2013) has opined that the state of 
drug supply chain affected availability, affordability and acceptability dimensions of 
medicines access. They suggest that failures of in-country supply chains to operate 
effectively and efficiently can erode all the success achieved in earlier stages of the 
supply chain. Lengthy public distribution systems have also been identified by Tetteh & 
Pharm (2009) cited in Kanyoma & Khomba (2013) as one factor affecting availability of 
medicines and therefore healthcare delivery. They note that such situations are 
common where distribution systems involve delivering of drugs to central warehouses, 
wherein they are then transferred to regional and district warehouses before being 
delivered to health facilities. Such chains of non-value adding and time consuming 
activities comprise what Taiichi Ohno, in Bailey et al, (2005) refers to as „the waste of 
unnecessary movements‟. Tetteh & Pharm (2009) cited in Kanyoma & Khomba (2013) 
precisely indicate that these lengthy distribution systems, coupled with lack of extensive 
information systems are responsible for frequent drug stock-outs and shortages in 
African nations. 
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d. Accountability 
Accountability is government's obligation to demonstrate effectiveness in   carrying   out   
goals   and   producing   the   types   of   services   that   the public wants and    needs 
(Segal and Summer 2002 cited by Ngugi & Mugo,n.d). Lack    of accountability creates 
opportunities for corruption. Brinkerhoff (2004) cited by Ngugi & Mugo (n.d) identifies     
three    key   components        of  accountability,      including    the measurement of 
goals and results, the justification or explanation of those     results   to  internal   or  
external    monitors,     and   punishment       or sanctions for non-performance or 
corrupt behaviour. Ngugi & Mugo(n.d) point out that there are many strategies which 
help increase   accountability and these  include   information   systems   which  
measure how inputs   are   used    to  produce     outputs;    watchdog      organizations, 
health boards   or   other civic   organizations   to   demand   explanation of results; 
performance   incentives  to  reward    good    performance;   and sanctions   for  poor   
performance. 
e. Ethics 
According to Wee (2002) cited in Ngugi and Mugo(,n.d.) ethics are the moral principles 
or values that guide   officials   in   all aspects  of   their   work.    Ethical   behaviour 
encompasses   the concepts of honesty, integrity, probity,   diligence, fairness,    trust,   
respect   and consistence.  According to Wee (2002) cited in Ngugi & Mugo(n.d) ethical   
behaviour    includes avoiding    conflicts of  interest,   and   not  making improper use   
of  an individual's    position. Therefore, ethical behaviour is   important      in   public 
procurement   as   it   involves   the   expenditure   of   public   money,   and   is subject 
to public scrutiny (Ngugi &Mugo,n.d). Public officials should always behave ethically   
and   fairly,   including   in   their   business   undertakings. Ethical behaviour supports 
openness and accountability in a procurement process and gives suppliers   confidence   
to   participate in   the Government marketplace (Ngugi &Mugo,n.d). 
2.9. Proper Logistic System 
According to Gordon (2010) a quality and sound logistic system supplies would ensure 
the safety and efficacy of the products by routinely checking for quality throughout the 
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procurement and distribution process. He further opined that clear and comprehensive 
product specifications are the first step in quality assurance followed by routine 
sampling and testing during manufacture and upon receipt. Subsequently the 
distribution system provides quality assurance by tracking   expiration   dates and    
ensuring    good   storage   and    handling practices in order to have an effective, 
accessible and continuity of health care services Gordon, (2010). 
According to the (WHO 2004), “Essential medicines are intended to be available within 
the context of functioning health systems at all times in adequate amounts, in the 
appropriate dosage forms, with assured quality and adequate information, and at a price 
the individual and the community can afford”. In this view, these medicines should be 
widely available and closely monitored (WHO 2004).The whole essence of having the 
CMST is to have medicines and other medical supplies in the hospitals and other 
centres to assist in the diagnosis and treatment of various diseases. 
Since a full supply chain consists of interconnected yet distinct functions, inaccuracy, 
inefficiency, or weakness at any point may compromise the strength of the entire supply 
chain. A disruption anywhere along a pharmaceutical supply chain may ultimately cause 
a stock out, or unavailability of health commodities. Stock outs can cause patients to 
miss treatments, and may increase risk of mortality if the disruption persists (Ikoh, M. et 
al 2008, cited by Whitney, (2010). Other intermediate outcomes of poor supply chains 
include product expiration, theft, overstocking, under stocking, order errors, and 
political/legal blocking (Supply Chain Management System, 2009 cited by 
Whitney,2010).It is also imperative for CMST to maintain a pharmaceutical supply chain 
that will not be disrupted because if this happens then there will be stock-outs of 
medicines and medical supplies in hospitals which will mean patients in the hospitals 
and other centres dying and those who can afford going to seek the medicines in private 
pharmacies. 
Wilson (2009) writes that, with the growing understanding of logistics management as 
an area of competitive advantage, logistics management still faces some problems 
because companies still consider logistic management functions as a separate part of 
their operations from other company activities.  Another key principle of logistics 
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management is figuring out the competitive areas they need to focus on in their 
operations.  Due to the continuous change in the logistics environment, it is important to 
take action promptly to fulfil customers‟ needs to help build and maintain customer 
value. Hence, only when logistics management strategies are based on the needs of 
the company, can they gain a competitive advantage (Gammelgaard & Larson, 2001 
cited by Odoom, (2012). 
It is therefore important for CMST to consider logistics environment to meet and fulfil 
customer needs. The efficient and effective logistics management will help in the 
continuous supply of medicines and medical supplies. 
2.10. Conclusion 
Procurement is a very essential but complex process that differs between countries 
based on funding sources, recipients and the regulations in place. Some of the 
procurement process challenges include lack of effective coordination and 
communication between stakeholders such as donors and government in funding, 
procuring and quantifying national needs. Besides, the lengthy and inflexible 
procurement procedures with very long lead times leading to frequent stock outs, such 
as long time lapses between tenders and deliveries, and inflexible supplier contracts. 
The chapter has therefore reviewed some literature regarding the topic under study. 
The next chapter that follows outlines the research method used for this study. 
 
 
 
 
 
 
 
25 
 
CHAPTER THREE: RESEARCH METHODOLOGY 
3.1. Introduction 
The chapter outlines the methodology which was used in this research study. Therefore 
information relating to research design, sampling methods, target population, and 
analysis of data has been given. 
 3.2. Research Methodology 
Research methodology as put by Collis and Hussey (2003) is defined as an approach to 
the entire process of the research study. The two common approaches used in research 
are qualitative and quantitative. Creswell (2009:70) defines qualitative research studies 
are focused on differences in quality, rather than differences in quantity commonly used 
to go deeper into issues of interest and explore nuances related to the problem at hand. 
Common data collection methods used in qualitative research are focus groups, triads, 
dyad, in-depth interviews, uninterrupted observation, bulletin boards, and ethnographic 
participation/observation. Qualitative research is more exploratory thereby providing an 
opportunity to discover new issues but is however more prone to accusations of bias 
and personal subjectivity 
Quantitative research according to Creswell (2009:70) focus on numeric analysis and 
statistics with the purpose of quantify the problem and understand how prevalent it is by 
looking for projectable results to a larger population. According to Bryman & Bell (2011) 
qualitative approach is used in interpretivism where there is need to generate or prove a 
theory. Therefore, considering the study and the type of data required both quantitative 
and qualitative approaches will be used. 
 
 
 
 
 
26 
 
Figure 3.1. Research Onion 
 
Source: Saunders et al (2009) 
3.3. Research Philosophy 
According to Saunders et al. (2012:127) research philosophy relates to the way in which 
knowledge is developed and the nature of that knowledge. Business research methods 
are based on the philosophy of science and the theory of the society. Two research 
approaches exist, the positivist approach and the interpretivism approach and have 
been used in this research.    
 
3.3.1. Interpretivism 
This will be an interpretivism research. Bryman & Bell (2007) describe interpretivism 
philosophy as one which is concerned with the understanding of the human behaviour 
in social science. The researcher expects subjective responses because the answers to 
be provided would depend on the perceptions as whether the Trust has contributed 
positively or negatively to the availability of medicines and medical supplies.   
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3.3.2. Positivist Approach 
The positivist approach also referred to as the quantitative approach is founded on a 
belief that the study of human behavior should be conducted in the same way as 
studies conducted in the natural sciences (Collis and Hussey, 2003:52). Welman et al 
(2011:6) contend that the positivist approach underlies the natural scientific method in 
human behavioural research and holds that research must be limited to what we can 
observe and measure objectively, which exists independently of the feelings and 
opinions of individuals. 
 
3.4. Research Approach 
There are two approaches that are used in research and these are deductive and 
inductive. Deductive research approach involves the testing of a theoretical proposition 
by employing a research strategy specifically designed for the purpose of its testing, 
while inductive approach is that which involves the development of a theory as a result 
of the observation of empirical data. Saunders (2003,p.85), has opined that every 
research will involve the use of theory, it may not be apparent during the research 
design but it is more explicit during presentation and findings. The deductive approach 
is biased towards natural sciences in which a cause and effect link is made between 
particular variables without an understanding of how humans interpret the social world. 
As such the research approach to be adopted for the study is inductive where a 
substantial theory review has already been developed but hypothesis will be tested and 
this will lead to the conclusion. 
3.5. Research Strategy 
There are a number of research strategies that a research may be able to employ, 
namely, experiment, case study, grounded theory, ethnography, survey and action 
research (Bryman 2004,p.84). Research design provides the glue that holds the 
research project together. For the purpose of this research a case study was chosen 
because it provides more realistic responses than a purely statistical survey. 
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3.6. Target Population 
The target population of this study will be 100 individuals and will be drawn from health 
related institutions from the three regions of Malawi. This number covers all personnel 
working in hospitals and health centres from which a sample of 30 respondents has 
been drawn to be interviewed. 
3.7. Sample of the Study 
According to Singh (2007, p88) sampling frame is defined “as a subset of the 
population, which   provides    a   broad    and   detailed   framework for selection of 
sampling units”.  A sample size is the number of participants in a study and in this case 
30 respondents will be drawn from health related institutions. The individuals to be 
interviewed will come from health related institutions and will include clinicians, District 
Health Officers, Pharmacy Personnel and CMST Procurement and senior management. 
3.8. Sampling Method 
There are several methods that a researcher can make a selection from. Ghauri and 
Gronhaug (2005) opine that sampling methods are divided into probability and non-
probability sampling. Examples of probability sampling include simple random, stratified 
sampling, cluster sampling and systematic sampling while non-probability examples 
include convenience, purposive and snowball sampling. This researcher used simple 
random and purposive sampling method to select a sample for this research study. 
3.9. Sources of Data 
Sources of data can be primary, secondary and even tertiary according to Saunders et 
al. (2009:23). The study used two forms of data; primary and secondary data as 
described in section 3.9.1 and section 3.9.2 below. 
 
3.9.1. Sources of Primary Data 
The study used some primary sources of data to answer the research questions. 
According to Gratton and Jones (2010:8) primary data is data gathered for the purpose 
of the research which can be collected through methods such as questionnaires, 
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interviews, etcetera. The primary data was collected using an interview guide (Appendix 
A). 
3.9.2. Sources of Secondary Data 
Secondary data is the data gathered through existing resources such as census, 
archives, etcetera (Gratton & Jones, 2010:8). The secondary data was obtained from 
monthly stock status reports from the health related institutions including CMST. This 
was meant to assess the stock outs, under stocks and over stocks so that a comparison 
regarding the current performance in the supply and availability of medicines can be 
done 
 
3.10. Data Collection Instrument 
Data was collected through structured interviews. Interviews are good because there is 
chance to build rapport and thereby increases chances of getting enough information by 
clarifying questions to the respondents when not clear(Khotari,2006). However, 
interviews are time consuming, while questionnaires either open or close ended are 
good because they are free from bias, time and cost effective considering that the 
researcher is an employee and time is one of the constraints (Saunders, Lewis, & 
Thornhill (2009).  
3.11. Pilot Study 
A pilot study of the research instrument was carried out to 5 participants in the selected 
health related organizations who were not part of the main study to test the flow of 
questions and validity and also assessing how respondents would answer the questions 
asked. Therefore, before the data gathering phase a pilot test should be done 
(Saunders et al 2009).  
3.12. Data Analysis 
There are several methods and tools that can be used to analyse the collected data. 
Data analysis is the process of analysing all the information and evaluating the relevant 
information that can be helpful in better decision making (Sivia& Skilling 2006). Data 
was analysed using Microsoft Excel and presented qualitatively and quantitatively. 
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3.13. Credibility of Qualitative Research 
Lincoln and Guba, as cited by Trochim (2006), proposed four criteria for judging 
soundness of a qualitative research. The criteria are credibility, transferability, 
dependability and confirmability. Credibility involves establishing that the results of the 
research are credible or believable in the eyes of the research participants. 
Transferability is the degree to which the results of the research can be generalized or 
transferred to other contexts or settings and is the responsibility of the person 
transferring the results to a different context. Dependability requires the researcher to 
account for the ever-changing context within which the research is taking place by 
describing the changes that occur and how the changes affected approach of the study. 
Confirmability refers to the extent to which results of the research can be confirmed or 
collaborated by others. Confirmability can be enhanced in many ways, one of which 
could be through documenting procedures for checking and rechecking data throughout 
the study. 
 
3.14. Ethical Considerations 
Saunders et al (2009) defines research ethics as the appropriateness of behaviour in 
relation to the rights of those who become subject of your work or are affected by it. 
Ethical consideration should be made to ensure that participants have given informed 
consent that no harm comes to participants, that confidentiality and anonymity of 
participants be protected and that permission is obtained to conduct the survey 
(Saunders et al.2009). 
 
3.14.1. Ensuring Participants’ Informed Consent 
The study ensured that participants composed all those concerned with the 
procurement process and were asked to give informed consent by providing sufficient 
information about the objectives of the questionnaire prior to their response. Further, the 
study explicitly asked respondents to physically tick in a “Consent box” indicating that 
they consented to participate in the study. 
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3.14.2  Ensuring no Harm Comes to Participants 
Although no direct or indirect harm was anticipated to occur to participants of this study, 
all respondents were not required to indicate their personal information that could 
directly link to them. To ensure there is no abuse of information, the data collected were 
treated with utmost confidentiality and was not to be shared with other parties. 
Furthermore, the collected data was aimed for the academic research project only. 
 
3.14.3  Confidentiality and Anonymity 
Confidentiality and anonymity of the research participants were protected by ensuring 
that their identities were not disclosed on the questionnaire forms since participants 
were not required to give their names. 
 
3.14.4  Ensuring that Permission was obtained 
Some letters shown in APPENDIX A were written to the organizations where the 
respondents were to be drawn to seek permission from senior management in order to 
conduct this study.  
 
3.15. Limitations of the Study 
According to Bui (2009,p.144) limitations can be inherent to the research design, data 
analysis, time and resources, or a condition that was set by the researcher. This study 
encountered several limitations that need to be highlighted. Low respondent turnout rate 
since samples was to be from hospitals throughout the country and expected limited 
access as the reliable technique of administering a questionnaire was through phone 
calls. Again financial resources for transport to other hospitals which are within reach, 
limited access to information about previous studies on the CMST as well as time; 
working and conducting research at the time. 
 
3.16 .Conclusion 
The chapter has outlined the research methodology process the researcher followed in 
the study such as research design and methodology. The target population of the 
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research were all those concerned with the procurement process. In view of the 
research instrument, interviews were used as data collection instrument. The method 
was used because it allows probing. When the interview questions were formulated they 
were piloted to those who were not going to take part in the actual study.  The research 
employed a case study method using an interview guide to purposively selected 
respondents. The data was collected from a sample of 30 respondents from a 
population of 100 people.  The data collected was analysed using the Microsoft Excel 
and presented qualitatively. Finally, issues of reliability and validity concerning data 
collection instrument was done including ethical considerations for respondents. The 
purpose of the study was explained to the participants,  and were assured on protection 
of identity and confidentiality.  
 
Data analysis will follow in Chapter 4 
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CHAPTER 4: DISCUSSION AND INTERPRETATION OF RESEARCH FINDINGS 
 
4.1 Introduction 
The  chapter discusses the results obtained from the study. As a qualitative study, an 
interview guide was prepared  to get information from the sampled participants to the 
study. The data was analysed  to give meaning as presented by the participants. 
 
4.2 Response rate 
A sample of 30 participants were considered but out of these 29 were interviewed.The 
participants comprised clinicians, District Health Officers from hospitals and health 
centers, Pharmacy Personnel, Procurement and CMST senior management. 
 
4.3. Analysis of the Research Findings 
The aim of the research was to critically assess the impact of procurement performance 
processes on availability of medicines and medical supplies. The study used qualitative 
research and the interview guide is found in the Appendix A. 
4.3.1. The supply of medicine and medical supplies at CMST 
The roles of the CMST have generally included the national procurement of healthcare 
commodities, storage and handling of inventory commodities, and distribution to various 
sections of the national public health system; and, in some cases, the private-sector 
health system. When the participants were asked on the stock level of supply of 
medicines and medical supplies the majority said that it was very low. The January 
2012 monthly report drawn at CMST indicated that the availability of medicine was at 
42% and in June 2012 was at 46% with a 4% improvement with stocks drastically falling 
in December 2012 about 23% representing a fall of 23% of the medicines and medical 
supplies available at CMST. It was earlier pointed out that ensuring a sustained 
availability of these health products in the health service delivery points in the country 
requires proper quantification, forecasting, procurement process, appropriate 
warehousing and effective distribution strategies. This therefore shows that there is 
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no stability in view of the availability of the medicines and medical supplies. To make 
matters worse some participants felt that the requested items for their units did not 
match their specifications. For example Participant 15 alluded that “units were given 
wrong items than what was requested while Participant 10 said that “technical staff is 
not even involved in drug management at CMST”. Successful   hospital    procurement  
is  also   a   collaborative     process, involving     people     with skills   in  purchasing, 
finance, management, clinical   and   nursing   specialties,   pharmacy,   quality   control,   
and   even the end user: the patient (Ombaka,2009). Besides, the majority felt that 
when the medicines and medical items were out of stock there was no alternative and 
this would result in the medical personnel prescribing drugs which could not match the 
disease or worse still being sent to go and buy the medicines in private pharmacies. 
Some participants have also mentioned the poor quantification and forecasting in the 
procurement of the medicines. Most of the health centres and hospitals depend on 
CMST for their medicines and medical supplies. The majority of the participants felt that 
if medicines and medical supplies were adequately available then people would not die 
from diseases that would be easily treated. It can be argued that it was important that 
CMST should be able to find out from the health centres and hospitals where drugs are 
supplied regarding the availability and checking expiry dates. 
 
4.3.2. The current performance on the supply of medicine and medical supplies at 
CMST 
The supply of medicines and medical supplies is very crucial in achieving health for all. 
When the question was posed to participants on how the lack of supply had affected the 
care provided, the majority of participants said that CMST was not supplying the units 
with the required quantities and sometimes not supplied at all. Inadequate planning and 
forecasting, use of archaic procurement methods, and tendering yearly or multiple times 
a year contribute to high commodity costs, long lead times, stock imbalances, and, 
overall, commodity insecurity(WHO 2011).  Indeed, across all WHO regions, the mean 
availability of selected medicines is consistently lower in the public sector than in the 
private sector (Cameron A, Ewen M, Ross-Degnan D, Ball D, Laing R 2009, p.373).This 
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then lead to stock out of essential medicines and sometimes tell patients to go and buy. 
Again some participants said that sometimes quality is compromised and products 
change colour. Participant 21 said that “we always receive drugs with short expiry 
dates” while Participant 25 says “when orders are due it takes very long for CMST to 
deliver”. In cementation of these comments, the January reports indicate that the stocks 
fell further in 2013 to 19% on availability of medicines from 23% in December 
2012.However, there was a slight percentage increase of 6% in December 2013 to 29% 
but fell again in January 2014 representing 23% though there was an improvement in 
December, 2014 to 61%.Thus this instability has led to stockouts in most health units. 
Lengthy public distribution systems have also been identified by Tetteh & Pharm (2009) 
cited in Kanyoma & Khomba (2013)as one factor affecting availability of medicines and 
therefore healthcare delivery. They note that such situations are common where 
distribution systems involve delivering of drugs to central warehouses, wherein they are 
then transferred to regional and district warehouses before being delivered to health 
facilities. These are some of the sentiments put forward by some of the participants 
during this study regarding the current performance on the supply of medicines and 
medical supplies.  
 
Then, according to Lapukeni (2012) the supply chain showed serious flaw, leading to 
intermittent supply to delivery sites. The evidence of this continuous shortage of health 
products is abundant as evidenced by the inability of the supply chain system to use the 
entire amount of the national budget for medicines and medical supplies. In view of the 
forgoing argument quantification, forecasting, lead times and other activities are crucial 
in making sure that medicines and medical supplies are available in hospitals. However, 
as alluded by a number of participants it is clear that CMST continues to have problems 
which meant lack of availability of medicines and medical supplies in hospitals and 
health centres. From the observation of Lapukeni (2012) it shows that CMST was still 
finding problems in trying to gain confidence from the units in terms of supply of 
medicines and medical supplies. Some other participants have pointed out that good 
procurement systems gains confidence and that good procurement would ensure 
constant availability of medicines. Besides, when products are not overstocked expiry is 
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avoided and then losses are reduced. Mabveka (2013) had also pointed out that 
mismanagement of funds could be another form in the form of how the contract 
payments were done. It could be possible that payments for the yet-to be and delivered 
drugs and medical supplies were not made per the contract agreements, hence 
affecting the procurement of drugs. For instance some contracts could require upfront 
payments but they were not made. This could have been the case either because the 
funds were not transferred from Treasury or were used for other things. 
 
As stock status reports have shown it is difficult to tell if CMST has enough medicines 
and medical supplies to supply to hospitals and health centres as shown by fluctuating 
percentages (See Appendix C). There are these falling percentages that make us 
wonder whether people get the treatment they are looking for or where do they get the 
treatment. Moreover, when the question asked to ascertain the time it takes for them to 
receive the medicines and medical supplies, the majority of participants mentioned 
between 3-6 weeks while some indicated 3-8 months. However, to receive the 
medicines and medical supplies it has to take 2 weeks for user units and not 3-6 weeks 
and to the CMST it is supposed to be within 16 weeks to receive from suppliers and not 
3-8 months. In a study undertaken in 2008 by USAID it was found that CMST had no 
skilled and enough staff which affected its supply chain management (Mabveka 2013). 
This meant that it had no adequate capacity to undertake procurement activities which 
includes procurement planning and management of the procurement process. 
The results have also shown that if the drugs are available the patients are treated with 
the right medication. Some participants also said that if the supply of medicines is 
adequate, it helps reduce costs because emergency procurement is expensive. In this 
view the majority of participants have argued that the supply of medicines and medical 
supplies was not good enough to warrant the units totally confidence in CMST. 
 
4.4.3. Changes that have been observed at CMST in supply of medicine and 
medical supplies 
According to Lapukeni (2012) the supply chain showed serious flaw, leading to 
intermittent supply to delivery sites and this is further highlighted below. The evidence of 
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this continuous shortage of health products is abundant as evidenced by the inability of 
the supply chain system to use the entire amount of the national budget for medicines 
and medical supplies. In view of the comparison with what is happening now it seems 
that there is no change at as the stock level of medicines and medical supplies at CMST 
still remains low as put forward by the majority of the participants sampled for this study. 
For instance, Participant 1 said “the Malawi Standard Treatment Guidelines is not 
updated regularly hence new drugs are not included on essential medicines list for 
CMST to procure”. In addition Participant 2 asserted that “political interference had an 
influence on procurement decision. Further challenges come as a result of forces 
external to procurement. On this, Vries (2010) argues that inventory management 
decisions for hospitals are often made by many stakeholders who have conflicting 
interests. He notes that such decisions often seem to be more politically and 
experience-based rather than data-driven and potentially affect availability.  For 
example, the January 2012 monthly report as part of secondary data has shown that 
CMST had stocked about 2419 representing 42% while in January 2013 the stocked 
items were at 19%. The World Health Organization (WHO) defines access to medicine 
as a priority for citizens. It needs to be available at all times in adequate amounts, in 
appropriate dosage and quality and at an affordable price for individuals and 
communities (Marks, 2009 and Yadav et al., 2011 cited by Schopperle, 2013).This 
clearly shows that as the items are getting replenished there are not being replaced. 
Though this is the case some participants further felt that the delivery note in some 
cases never matched the actual stock being delivered and that there was mis-
procurement of these medicines and medical supplies. 
4.4. Conclusion 
An effective supply management system is very important in making sure that 
medicines and medical supplies are available in most of the health units. When the 
participants were asked on the stock level of supply of medicines and medical supplies 
the majority said that it was very low. The majority of the participants felt that if 
medicines and medical supplies were adequately available then people would not die 
from diseases that would be easily treated. Some participants further felt that the 
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delivery note in some cases never matched the actual stock being delivered and that 
there was mis-procurement of these medicines and medical supplies. When the 
question asked to ascertain the time it takes for them to receive the medicines and 
medical supplies, the majority of participants mentioned between 3-6 weeks while some 
indicated 3-8 months. Again some participants said that sometimes quality is 
compromised and products change colour. When the question was posed to 
participants on how the lack of supply had affected the care provided, the majority of 
participants said that CMST was not supplying the units with the required quantities and 
sometimes not supplied at all. Besides, the majority felt that when the medicines and 
medical items were out of stock there was no alternative and this would result in the 
medical personnel prescribing drugs which could not match the disease or worse still 
being sent to go and buy the medicines in private pharmacies. Some participants have 
also mentioned the poor quantification and forecasting in the procurement of the 
medicines. 
 
The following chapter presents the overall conclusions and recommendations of the 
study 
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CHAPTER 5: CONCLUSIONS AND RECOMMENDATIONS 
5.1. Introduction 
This section outlines a summary of the study as well as giving conclusions and 
recommendations based on the research findings discussed in the previous chapter. 
The mentioned areas herein are according to the objectives cited in Chapter One. The 
objectives are as follows: 
 To review relevant literature on the supply of medicines and medical supplies at 
CMST. 
 To compare the current performance on supply of medicines and medical 
supplies at CMST with that previously found by Lapukeni (2012) research. 
 To investigate reasons for change between the two studies. 
This chapter gives recommendations on how to improve the situation. 
5.2. Findings from the Study 
The results of the study have revealed that there is low supply of medicines and medical 
supplies. 
5.3 Findings from Literature Review 
This part outlines conclusions drawn from scholars regarding the procurement 
processes regarding the availability of medicines and medical supplies. Some scholars 
have pointed out that the availability of medicines and medical supplies is crucial for 
achieving quality health care service. Further literature has revealed that to ensure a 
sustained availability of the health products in the health service delivery in the country 
required proper quantification, forecasting, procurement process, appropriate 
warehousing and effective distribution strategies. Other scholars have argued that a 
number of public    procurement   activities continue to suffer from neglect coupled with 
poor co-ordination, corruption levels as well as failure of open competition and 
transparency. 
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In addition, some scholars have said that procurement processes lack well trained and 
qualified personnel who could manage procurement effectively and professionally. On 
the other hand bureaucratic systems of   procurement have contributed towards    
unacceptable contract delays, increased costs as a result of delays which a larger 
population will perceive as slow, ineffective and often corrupt. It is equal important that 
procurement process should take a collaborative process with specialists playing a 
major role. 
From the literature reviewed some scholars have found inadequate planning and 
forecasting, use of archaic procurement methods, and long lead times as elements 
affecting the availability of medicines and medical supplies. It has also been found that 
availability of medicines and medical supplies is high in private sector than in public 
hospitals and other health centres. The evidence of this continuous shortage of health 
products is abundant as evidenced by the inability of the supply chain system to use the 
entire amount of the national budget for medicines and medical supplies. 
Moreover, the facilities which are hospitals and health centres have developed lack of 
confidence in Central Medical Stores leading to procurement of health products from the 
private suppliers usually at a prohibitive higher cost and thus confirming the erratic and 
unreliable nature of the supply chain system. A different factor for the shortage of drugs 
and medical supplies could be unavailability of skilled and enough staff at the CMST. 
Søreide (2002) (cited by Heggstad, K et al. (2010) and cited by Mabveka (2013) 
states:“Corruption in public procurement makes the officials or the politicians in charge 
purchase goods or services from the best briber, instead of choosing the best price-
quality combination”. The foregoing clearly shows that politicians do contribute into to 
the occurrence of procurement corruption. This simply means that politicians do conflict 
and struggle with the legitimate primary players in the public procurement who happens 
to be public officer/officials, later alone other secondary players in the public 
procurement process.   
Furthermore, some scholars have said that effective inventory management in a supply 
chain could play a pivotal role in trying to reduce the inventory holding costs across the 
different stages of the supply chain. In case of a health facility excess inventory may 
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lead to expiry of some medicines. It has been also argued that mismanagement of 
funds can also lead to problems in medicine and medical supplies by suppliers who 
might have affected by contract agreements, hence affecting the procurement of drugs. 
For instance some contracts could require upfront payments but they were not made. 
This could have been the case either because the funds were not transferred from 
Treasury or were used for other things and at the end having a thin budget for the 
essential drugs. 
 
5.4. Findings from the Primary Research  
The results of the study reveal that the stock level of supply of medicines and medical 
supplies is not good and the situation has not fully improved taking from the previous 
study by Lapukeni(2012).The majority of the participants interviewed said that stock 
level of supply was very low followed by those who said it was moderate. Most of the 
participants interviewed in this study said that CMST management lacked strategic 
planning and also poor quantification while some cited political interference and that the 
medicines and medical supplies had a short expiry date. As pointed in the stock status 
report, the decrease in percentages of the available medicine and medical supplies 
shows that nothing tangible has changed at CMST in terms of the procurement 
processes to have medicine in hospitals and other health centres. The participants were 
concerned that sometimes CMST recalls products but does not replace and this leads 
to many patients being returned and to buy medicines and other medical supplies to 
private pharmacies while some have said that the requested items are not supplied in 
full.  
 
Again, most of the participants interviewed revealed that lack of medicine and medical 
supplies meant failing to give medicines to all the patients throughout the year and 
when products that did not match are returned CMST does not replace and this leads to 
stock outs. The participants in the study strongly said that there had no alternative of 
getting medicines and medical supplies while others said would place emergency 
orders other than open tender. Moreover, most participants also revealed that good 
procurement will ensure constant availability of medicines all the time. Some have said 
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that when products are not overstocked expiry is avoided and hence losses are 
reduced. Again when asked about the advantages of good procurement and inventory 
management of drugs, other participants revealed that potency of medicine can be 
maintained through good inventory management.  
 
5.5. Conclusions 
Procurement of medicines and medical supplies is one of the activities that are 
performed by CMST. If medicines are not procured well and not available in the 
hospitals and other health centres this may mean that the innocent patient who is also a 
tax payer may not get the required medicine for treatment. When some of these drugs 
have expired and have been recalled there is need for them to be replaced. In this way 
the budget of these health centres and hospitals will be maintained but if not then they 
would end up spending out of the budget. It is imperative that management of CMST 
ensures that medicines and medical supplies are not lacking in the hospitals and health 
centres. 
 5.6. Recommendations 
5.6.1. There is need for the government to give CMST adequate funding. This will 
enable CMST to procure adequate medicines and medical supplies. 
5.6.2. There is need to streamline the procurement process by revising and 
reducing the number of stakeholders. 
5.6.3. There is also need for CMST to set priorities through consultations. This 
means that the CMST should consult different specialists in the medical field 
in order to procure medicines which are required. 
5.6.4. There is need for regular review of Malawi Standard Treatment Guidelines. 
5.6.5. Moreover, after recalling the medicines and medical supplies, CMST should 
make an effort of replacing them. When drugs and other medical supplies 
have been recalled either due to poor specification or expiry date there is 
need to replace them otherwise if not replaced there would be shortage that 
would be created. 
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5.6.6. There is need for the procurement unit to be at strategic level in the CMST 
organogram. By being at the centre of strategic level the procurement will 
play its role in getting appropriate drugs through appropriate specifications 
5.6.7. There is also need for proper quantification and forecasting of requirements. 
This will help a lot in obtaining medicines and medical supplies which are 
essential  
5.6.8. Looking at the trend of medicines and medical supplies from stock status 
reports it is clear that the country faces a bigger problem in terms of 
availability of medicines. For example, a one month stock status report 
indicated 23% availability of medicines and medical supplies which means   
67% were not available. Then how are people being treated? 
 
5.7. Area for further Research  
A further study could be carried out on the effects in health centres and hospitals 
caused by poor procurement processes. 
 
5.8. Conclusion 
The procurement process is an essential component of many organisations. Therefore, 
lack of procurement of medicines and medical supplies will affect the innocent patient. It 
has been noted that there is poor quantification and forecasting of medicines and 
medical supplies. There is need for CMST to have adequate funds for the procurement 
of essential medicines. The lack of funds to be used in the procurement of drugs 
continues to affect many facilities whose core business is supported by CMST. In order 
to avoid the expiry of medicines and medical supplies, there is need to have an effective 
inventory management system. Lack of on job training with special emphasis on 
storage, handling and lack of or improper quantification and forecasting at healthcare 
facility level appear to be some of the factors which cause stock out. Poor or lack of 
proper storage conditions in the health facility also hinder effective distribution system 
because in order for a vaccine to maintain its efficacy it required good storage condition 
from point of manufacture up to point of administration. Thus, an implementation of 
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effective procurement processes will ensure availability of medicines and medical 
supplies in health centres and hospital. 
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APPENDIX A: INTERVIEW GUIDE 
1. PERSONAL DATA 
 
a) Age 
 
20-29  
30-39  
40-49  
50-60  
 
b) Sex 
 
 
Male  
Female  
 
c) Educational Level 
 
 
Junior Certificate of Education  
Malawi School Certificate of 
Education 
 
Professional Certificate/Diploma   
Basic Degree    
Master‟s Degree  
Other(specify)  
 
 
d) Profession 
District Hospital officer  
Pharmacists  
Procurement Officer   
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Purchasing Officer  
Clinicians  
 
 
e) Work Experience 
1-3 Years  
4-6 Years  
7-9 Years  
Over 10 Years  
 
2. What is the level of supply of medicines and medical supplies at CMST? 
   
………………………………………………………………………………………………………
………………………………………………………………………………………………………
…………………………………………………………………………………………………….. 
3. How have the poor procurement process at CMST affected hospitals and health 
centres in the supply of MMS? 
………………………………………………………………………………………………………
………………………………………………………………………………………………………
………………………………………………………………………………………………………
………………………………………………………………………………………………. 
4. Do you have any alternative way of getting MMS? If you have explain 
………………………………………………………………………………………………………
………………………………………………………………………………………………………
…………………………………………………………………………………………………….. 
5. What are the possible advantages of having an efficient and effective quantification 
process in the procurement and inventory management of drugs? 
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………………………………………………………………………………………………………
………………………………………………………………………………………………………
……………………………………………………………………………………………………… 
6. What is the minimum safety stock set for drugs? Do you reach this target? 
…………………………………………………………………………………………………….. 
7. What do you think are the reasons for stock  out of drugs and other medical supplies? 
………………………………………………………………………………………………………
………………………………………………………………………………………………………
……………………………………………………………………………………………………… 
 
8. Do you have guidelines for procurement and inventory management system? If yes, 
give the guidelines. 
………………………………………………………………………………………………………
………………………………………………………………………………………………………
…………………………………………………………………………………………………….. 
 
9. What is the procurement period that is normally used in your organisation? 
………………………………………………………………………………………………………
………………………………………………………………………………………………………
……………………………………………………………………………………………………… 
10. How much time does it normally take for you to receive the MMS? 
………………………………………………………………………………………………………
………………………………………………………………………………………………………
…………………………………………………………………………………………………….. 
 
 
11. What are some of the challenges you face when there is low supply of MMS? 
………………………………………………………………………………………………………
………………………………………………………………………………………………………
…………………………………………………………………………………………………… 
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12. In your opinion, what should be done in order to improve the procurement process 
of medicine and medical supplies at CMST? 
………………………………………………………………………………………………………
………………………………………………………………………………………………………
…………………………………………………………………………………………………….. 
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Appendix C 
JANUARY 2012 STOCK STATUS REPORT 
CLASS OF 
ITEMS 
TOT
AL 
NUM
BER 
OF 
ITEM
S 
 TOTAL 
FIRST 
PRIORIT
Y ITEMS 
(A) 
TOTAL 
SECOND 
PRIORIT
Y ITEMS 
(B) 
TOTAL 
NUMBER 
OF ITEMS 
AVAILABL
E 
FIRST 
PRIORITY 
ITEMS 
AVAILABL
E (A) 
SECOND 
PRIORITY 
ITEMS 
AVAILABL
E (B) 
PERCENTAG
E NUMBER 
OF ITEMS 
AVAILABLE 
CLASS A 138 99 39 74 64 10       54  
CLASS B 93 59 34 59 50 9       63  
CLASS C 7 3 4 4 4         57  
CLASS D 45 26 19 15 11 4       33  
CLASS E 115 81 34 66 54 12       57  
CLASS F 40 26 14 23 14 9       58  
CLASS G 92 56 36 45 34 11       49  
CLASS H 578 302 276 169 135 34       29  
CLASS K 12 8 4 7 5 2       58  
CLASS L 93 15 78 36 27 9       39  
CLASS M 525 191 334 213 168 45       41  
CLASS N 149 56 93 51 38 13       34  
CLASS P 245 157 88 84 61 23       34  
CLASS R 22 17 5 13 7 6       59  
TB PROGRAM 84 55 29 46 39 7       55  
FP PROGRAM 7 7 0 5 5         71  
STI PROGRAM 24 24 0 17 17         71  
GF PROGRAM 147 147 0 91 91         62  
DF PROGRAM 3 3 0 2 2         67  
TOTAL 2,419 1,332 1,087 1,020 826 194       42  
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JUNE  2012 STOCK STATUS REPORT 
CLASS OF 
ITEMS 
TOTAL 
NUMBE
R OF 
ITEMS 
 TOTAL 
FIRST 
PRIORI
TY 
ITEMS 
(A) 
TOTAL 
SECOND 
PRIORIT
Y ITEMS 
(B) 
TOTAL 
NUMBER 
OF ITEMS 
AVAILAB
LE 
FIRST 
PRIORITY 
ITEMS 
AVAILAB
LE (A) 
SECOND 
PRIORITY 
ITEMS 
AVAILABLE 
(B) 
PERCENTAG
E NUMBER 
OF ITEMS 
AVAILABLE 
CLASS A 138 99 39 71 55 16        51  
CLASS B 93 59 34 57 46 11        61  
CLASS C 7 3 4 5 5          71  
CLASS D 45 26 19 17 13 4        38  
CLASS E 115 81 34 69 56 13        60  
CLASS F 40 26 14 22 17 5        55  
CLASS G 92 56 36 49 40 9        53  
CLASS H 578 302 276 224 182 42        39  
CLASS K 12 8 4 7 7          58  
CLASS L 93 15 78 46 32 14        49  
CLASS M 525 191 334 216 149 67        41  
CLASS N 149 56 93 61 40 21        41  
CLASS P 245 157 88 99 88 11        40  
CLASS R 22 17 5 14 14          64  
TB PROGRAM 84 55 29 45 30 15        54  
FP PROGRAM 7 7 0 6 6          86  
STI 
PROGRAM 
24 24 0 15 15          63  
GF 
PROGRAM 
147 147 0 98 98          67  
DF 
PROGRAM 
3 3 0 2 2          67  
TOTAL 2,419 1,332 1,087 1,123 895 228        46  
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DECEMBER 2012 STOCK STATUS REPORT 
CLASS OF 
ITEMS 
TOTA
L 
NUM
BER 
OF 
ITEM
S 
 TOTAL 
FIRST 
PRIORIT
Y ITEMS 
(A) 
TOTAL 
SECOND 
PRIORIT
Y ITEMS 
(B) 
TOTAL 
NUMBER 
OF ITEMS 
AVAILABL
E 
FIRST 
PRIORITY 
ITEMS 
AVAILABL
E (A) 
SECOND 
PRIORITY 
ITEMS 
AVAILABL
E (B) 
PERCENTAG
E NUMBER 
OF ITEMS 
AVAILABLE 
CLASS A 138 99 39 48 42 6        35  
CLASS B 93 59 34 42 31 11        45  
CLASS C 7 3 4 2 2          29  
CLASS D 45 26 19 7 4 3        16  
CLASS E 115 81 34 31 23 8        27  
CLASS F 40 26 14 19 12 7        48  
CLASS G 92 56 36 36 32 4        39  
CLASS H 578 302 276 99 76 23        17  
CLASS K 12 8 4 3 3          25  
CLASS L 93 15 78 17 10 7        18  
CLASS M 525 191 334 103 72 31        20  
CLASS N 149 56 93 44 32 12        30  
CLASS P 245 157 88 29 24 5        12  
CLASS R 22 17 5 7 7          32  
TB 
PROGRAM 
84 55 29 17 13 4        20  
FP 
PROGRAM 
7 7 0 2 2          29  
STI 
PROGRAM 
24 24 0 9 9          38  
GF 
PROGRAM 
147 147 0 44 44          30  
DF 
PROGRAM 
3 3 0 2 2          67  
TOTAL 2,419 1,332 1,087 561 440 121        23  
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JANUARY 2013 STOCK STATUS REPORT 
CLASS OF 
ITEMS 
TOTAL 
NUMBE
R OF 
ITEMS 
 TOTAL 
FIRST 
PRIORI
TY 
ITEMS 
(A) 
TOTAL 
SECOND 
PRIORIT
Y ITEMS 
(B) 
TOTAL 
NUMBER 
OF ITEMS 
AVAILAB
LE 
FIRST 
PRIORITY 
ITEMS 
AVAILABL
E (A) 
SECOND 
PRIORITY 
ITEMS 
AVAILABL
E (B) 
PERCENTAGE 
NUMBER OF 
ITEMS 
AVAILABLE 
CLASS A 138 99 39 46 41 5           33  
CLASS B 93 59 34 38 32 6           41  
CLASS C 7 3 4 3 3 0           43  
CLASS D 45 26 19 9 6 3           20  
CLASS E 115 81 34 51 40 11           44  
CLASS F 40 26 14 11 6 5           28  
CLASS G 92 56 36 31 25 6           34  
CLASS H 578 302 276 62 46 16           11  
CLASS K 12 8 4 3 3             25  
CLASS L 93 15 78 16 7 9           17  
CLASS M 525 191 334 71 55 16           14  
CLASS N 149 56 93 31 24 7           21  
CLASS P 245 157 88 21 18 3             9  
CLASS R 22 17 5 12 9 3           55  
TB 
PROGRAM 
84 55 29 41 34 7           49  
FP 
PROGRAM 
7 7 0 4 4             57  
STI 
PROGRAM 
24 24 0 3 3             13  
GF 
PROGRAM 
147 147 0 15 15             10  
DF 
PROGRAM 
3 3 0 1 1             33  
TOTAL 2,419 1,332 1,087 469 372 97           19  
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DECEMBER 2013 STOCK STATUS REPORT 
CLASS OF 
ITEMS 
TOTAL 
NUMB
ER OF 
ITEMS 
 TOTAL 
FIRST 
PRIORIT
Y ITEMS 
(A) 
TOTAL 
SECOND 
PRIORIT
Y ITEMS 
(B) 
TOTAL 
NUMBER 
OF ITEMS 
AVAILABL
E 
FIRST 
PRIORITY 
ITEMS 
AVAILABL
E (A) 
SECOND 
PRIORITY 
ITEMS 
AVAILABL
E (B) 
PERCENTAG
E NUMBER 
OF ITEMS 
AVAILABLE 
CLASS A 138 99 39 56 40 16          41  
CLASS B 93 59 34 55 49 6          59  
CLASS C 7 3 4 3 3            43  
CLASS D 45 26 19 16 11 5          36  
CLASS E 115 81 34 45 32 13          39  
CLASS F 40 26 14 17 13 4          43  
CLASS G 92 56 36 44 36 8          48  
CLASS H 578 302 276 91 79 12          16  
CLASS K 12 8 4 7 3 4          58  
CLASS L 93 15 78 15 9 6          16  
CLASS M 525 191 334 156 137 19          30  
CLASS N 149 56 93 52 41 11          35  
CLASS P 245 157 88 47 40 7          19  
CLASS R 22 17 5 11 7 4          50  
TB 
PROGRAM 
84 55 29 52 38 14          62  
FP 
PROGRAM 
7 7 0 4 4            57  
STI 
PROGRAM 
24 24 0 3 3            13  
GF 
PROGRAM 
147 147 0 15 15            10  
DF 
PROGRAM 
3 3 0 1 1            33  
TOTAL 2,419 1,332 1,087 690 561 129          29  
 
 
 
 
 
 
61 
 
JANUARY 2014 STOCK STATUS REPORT 
CLASS OF 
ITEMS 
TOTA
L 
NUM
BER 
OF 
ITEM
S 
 TOTAL 
FIRST 
PRIORIT
Y ITEMS 
(A) 
TOTAL 
SECOND 
PRIORIT
Y ITEMS 
(B) 
TOTAL 
NUMBER 
OF ITEMS 
AVAILABL
E 
FIRST 
PRIORITY 
ITEMS 
AVAILABL
E (A) 
SECOND 
PRIORITY 
ITEMS 
AVAILABL
E (B) 
PERCENTAG
E NUMBER 
OF ITEMS 
AVAILABLE 
CLASS A 138 99 39 59 50 9         43  
CLASS B 93 59 34 49 41 8         53  
CLASS C 7 3 4 3 3 0         43  
CLASS D 45 26 19 7 7 0         16  
CLASS E 115 81 34 49 44 5         43  
CLASS F 40 26 14 22 21 1         55  
CLASS G 92 56 36 30 27 3         33  
CLASS H 578 302 276 91 75 16         16  
CLASS K 12 8 4 2 1 0         17  
CLASS L 93 15 78 16 8 8         17  
CLASS M 525 191 334 88 48 40         17  
CLASS N 149 56 93 29 23 6         19  
CLASS P 245 157 88 48 29 19         20  
CLASS R 22 17 5 11 10 1         50  
TB 
PROGRAM 
84 55 29 38 34 4         45  
FP 
PROGRAM 
7 7 0 5 5 0         71  
STI 
PROGRAM 
24 24 0 3 1 0         13  
GF 
PROGRAM 
147 147 0 15 7 0         10  
DF 
PROGRAM 
3 3 0 2 0 0         67  
TOTAL 2,419 1,332 1,087 567 434 120         23  
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DECEMBER  2014 STOCK STATUS REPORT 
CLASS OF 
ITEMS 
TOTA
L 
NUM
BER 
OF 
ITEM
S 
 TOTAL 
FIRST 
PRIORIT
Y ITEMS 
(A) 
TOTAL 
SECOND 
PRIORIT
Y ITEMS 
(B) 
TOTAL 
NUMBER 
OF ITEMS 
AVAILABL
E 
FIRST 
PRIORITY 
ITEMS 
AVAILABL
E (A) 
SECOND 
PRIORITY 
ITEMS 
AVAILABL
E (B) 
PERCENTAG
E NUMBER 
OF ITEMS 
AVAILABLE 
CLASS A 138 99 39 96 80 16           70  
CLASS B 93 59 34 71 62 9           76  
CLASS C 7 3 4 5 3 2           71  
CLASS D 45 26 19 26 21 5           58  
CLASS E 115 81 34 71 60 11           62  
CLASS F 40 26 14 32 26 6           80  
CLASS G 92 56 36 62 51 11           67  
CLASS H 578 302 276 316 268 48           55  
CLASS K 12 8 4 7 6             58  
CLASS L 93 15 78 48 42 6           52  
CLASS M 525 191 334 302 281 21           58  
CLASS N 149 56 93 88 79 9           59  
CLASS P 245 157 88 158 146 12           64  
CLASS R 22 17 5 12 8 4           55  
TB 
PROGRAM 
84 55 29 45 42 3           54  
FP 
PROGRAM 
7 7 0 5 5             71  
STI 
PROGRAM 
24 24 0 16 16             67  
GF 
PROGRAM 
147 147 0 124 78             84  
DF 
PROGRAM 
3 3 0 2 2             67  
TOTAL 2,419 1,332 1,087 1,486 1,276 163           61  
 
